S. H. Ralston

Publication List Details

Period

1986 - 2009

Number

65

Co-Authors

Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells (2009)

Idris, A.I., Sophocleous, A., Landao-Bassonga, E., Merkouris, M., Milligan, G., Baker, D., ...

Osteoporosis is characterised by reduced bone formation with replacement of the bone marrow compartment by fat, due to an age-dependent reduction in osteoblast differentiation and a reciprocal...

Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study (2008)

Langdahl, B.L., Uitterlinden, A.G., Ralston, S.H., Trikalinos, T.A., Balcells, S., Brandi, M.L., ...

INTRODUCTION: The TGFB1 gene which encodes transforming growth factor beta 1, is a strong candidate for susceptibility to osteoporosis and several studies have reported associations between bone...

Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosis (2006)

Reid, D.M., Mackay, I., Wilkinson, S., Miller, C., Schuette, D.G., Compston, J., ...

Osteoporosis is a common disease with a strong genetic component characterized by reduced bone mass and an increased risk of fragility fractures. Bone mineral density (BMD) is the most important...

Cross-calibration of dual-energy X-ray densitometers for a large, multi-center genetic study of osteoporosis (2006)

Reid, D. M., Mackay, I., Wilkinson, S., Miller, C., Schuette, D. G., Compston, J., ...

Osteoporosis is a common disease with a strong genetic component characterized by reduced bone mass and an increased risk of fragility fractures. Bone mineral density (BMD) is the most important...

Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study (2005)

Ralston, S. H., Galwey, N., MacKay, I., Albagha, O. M. E., Cardon, L., Compston, J. E., ...

Osteoporosis is a common disease with a strong genetic component, characterized by reduced bone mass and an increased risk of fracture. Bone mineral density (BMD) is a highly heritable trait and a...

Management of Paget's disease of bone (2004)

Langston, A. L., Ralston, S. H.

Paget's disease of bone is a common condition with a strong genetic component, characterized by focal increases in bone turnover, affecting one or more bones throughout the skeleton. Paget's disease...

Management of Paget's disease of bone (2004)

Langston, A. L., Ralston, S. H.

Paget's disease of bone is a common condition with a strong genetic component, characterized by focal increases in bone turnover, affecting one or more bones throughout the skeleton. Paget's disease...

Management of Paget's disease of bone (2004)

Langston, A. L., Ralston, S. H.

Paget's disease of bone is a common condition with a strong genetic component, characterized by focal increases in bone turnover, affecting one or more bones throughout the skeleton. Paget's disease...

Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35 (2001)

Herbert, C A, Nicholls, R K, Williams, F, Bennett, S T, Cundy, T, ...

Paget disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover. Genetic factors are important in the pathogenesis of PDB, and...

Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? (2001)

Eastell, R., Reid, D.M., Compston, J., Cooper, C., Fogelman, I., Francis, R.M., ...

The burden of non-vertebral fractures is enormous. Hip fractures account for nearly 10% of all fractures (and a much greater proportion in the elderly), while wrist fractures may account for up to...

Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action? (2001)

Eastell, R., Reid, D.M., Compston, J., Cooper, C., Fogelman, I., Francis, R.M., ...

The burden of non‐vertebral fractures is enormous. Hip fractures account for nearly 10% of all fractures (and a much greater proportion in the elderly), while wrist fractures...

Nitric oxide is a mediator of apoptosis in the rheumatoid joint (2000)

Van't Hof, R. J., Hocking, L., Wright, P. K., Ralston, S. H.

Objective. To study the role of nitric oxide (NO) derived from the inducible nitric oxide synthase (iNOS) pathway in the induction of apoptosis in the rheumatoid joint....

Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women (1998)

Uitterlinden, A.G., Burger, H., Huang, Q., Yue, F., McGuigan, F.E., Grant, S.F., ...

BACKGROUND: Osteoporosis is a common disorder with a strong genetic component. One way in which the genetic component could be expressed is through polymorphism of COLIA1, the gene for collagen type...

NITRIC OXIDE PRODUCTION IN CELLS DERIVED FROM THE HUMAN JOINT (1996)

GRABOWSKI, P. S., MACPHERSON, H., RALSTON, S. H.

We have investigated the ability of cells derived from the human joint to generate nitric oxide (NO). Synovial fibroblasts, articular chondrocytes and osteoblasts were cultured from tissues of...

CYTOKINE AND GROWTH FACTOR EXPRESSION IN PAGET'S DISEASE: ANALYSIS BY REVERSE-TRANSCRIPTTON/POLYMERASE CHAIN REACTION (1994)

RALSTON, S. H., HOEY, S. A., GALLACHER, S. J., ADAMSON, B. B., BOYLE, I. T.

We investigated expression of several cytokines and growth factors in explants of Pagetic and non-Pagetic bone samples using the technique of reverse-transcription/polymerase chain reaction...

HIGH PREVALENCE OF UNRECOGNIZED OSTEOMALACIA IN HOSPITAL PATIENTS WITH RHEUMATOID ARTHRITIS (1988)

RALSTON, S. H., WILLOCKS, LORNA, PITKEATHLY, D. A., MORTON, R., SMITH, G. D.

A consecutive series of 31 patients with rheumatoid arthritis (RA) admitted over a 6-month period to the rheumatology unit of a District General Hospital were screened for possible osteomalacia....

Humoral Hypercalcaemia of Malignancy: Metabolic and Histomorphometric Studies During Surgical Management of the Primary Tumour (1986)

RALSTON, S. H., BOYCE, B. F., COWAN, R. A., GARDNER, M. D., DRYBURGH, F. J., BOYLE, I. T.

Several aspects of calcium metabolism were studied in five patients during the surgical exploration of malignant tumours associated with humorally-mediated hypercalcaemia. Before operation in all...

Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption

Van't Hof, R. J., Armour, K. J., Smith, L. M., Armour, K. E., Wei, X. Q., Liew, F. Y., ...

Nitric oxide has been suggested to be involved in the regulation of bone turnover, especially in pathological conditions characterized by release of bone-resorbing cytokines. The cytokine IL-1 is...

Parathyroid hormone-related protein of malignancy: immunohistochemical and biochemical studies in normocalcaemic and hypercalcaemic patients with cancer.

Ralston, S H, Danks, J, Hayman, J, Fraser, W D, Stewart, C S, Martin, T J

Immunohistochemical staining for parathyroid hormone-related protein was performed in 27 tumours from 19 normocalcaemic and eight hypercalcaemic patients with cancer. All the tumours from...

Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.

Ralston, S H, Gardner, M D, Dryburgh, F J, Cowan, R A, Boyle, I T

The relation between urinary sodium excretion (NaE) and renal tubular calcium reabsorption (TmCa/GFR) was assessed in patients with hypercalcaemia associated with malignancy and primary...

Abnormal growth factor and cytokine expression in Dupuytren's contracture.

Baird, K S, Crossan, J F, Ralston, S H

AIM--To analyse patterns of gene expression for peptide regulatory factors in patients with Dupuytren's contracture. METHODS--Tissue samples (palmer fascia) from 12 patients with Dupuytren's...

Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.

Ralston, S H, Alzaid, A A, Gardner, M D, Boyle, I T

Eight patients with cancer associated hypercalcaemia were treated with the combination of aminohydroxypropylidene diphosphonate and salmon calcitonin for six days. Serum calcium concentration fell...

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

Ralston, S H, Fogelman, I, Gardiner, M D, Boyle, I T

Some relations between metastatic bone disease and calcium homoeostasis were determined in a consecutive series of 81 patients with solid malignant tumours attending for radionuclide bone scans....

Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis.

Ralston, S H, Urquhart, G D, Brzeski, M, Sturrock, R D

OBJECTIVE--To determine the prevalence of vertebral compression fractures due to osteoporosis in patients with ankylosing spondylitis. DESIGN--Prospective study of 111 consecutive patients; patients...

Requirement of the inducible nitric oxide synthase pathway for IL-1-induced osteoclastic bone resorption

Van't Hof, R. J., Armour, K. J., Smith, L. M., Armour, K. E., Wei, X. Q., Liew, F. Y., ...

Nitric oxide has been suggested to be involved in the regulation of bone turnover, especially in pathological conditions characterized by release of bone-resorbing cytokines. The cytokine IL-1 is...

Parathyroid hormone-related protein of malignancy: immunohistochemical and biochemical studies in normocalcaemic and hypercalcaemic patients with cancer.

Ralston, S H, Danks, J, Hayman, J, Fraser, W D, Stewart, C S, Martin, T J

Immunohistochemical staining for parathyroid hormone-related protein was performed in 27 tumours from 19 normocalcaemic and eight hypercalcaemic patients with cancer. All the tumours from...

Influence of urinary sodium excretion on the clinical assessment of renal tubular calcium reabsorption in hypercalcaemic man.

Ralston, S H, Gardner, M D, Dryburgh, F J, Cowan, R A, Boyle, I T

The relation between urinary sodium excretion (NaE) and renal tubular calcium reabsorption (TmCa/GFR) was assessed in patients with hypercalcaemia associated with malignancy and primary...

Abnormal growth factor and cytokine expression in Dupuytren's contracture.

Baird, K S, Crossan, J F, Ralston, S H

AIM--To analyse patterns of gene expression for peptide regulatory factors in patients with Dupuytren's contracture. METHODS--Tissue samples (palmer fascia) from 12 patients with Dupuytren's...

Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.

Ralston, S H, Alzaid, A A, Gardner, M D, Boyle, I T

Eight patients with cancer associated hypercalcaemia were treated with the combination of aminohydroxypropylidene diphosphonate and salmon calcitonin for six days. Serum calcium concentration fell...

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

Ralston, S H, Fogelman, I, Gardiner, M D, Boyle, I T

Some relations between metastatic bone disease and calcium homoeostasis were determined in a consecutive series of 81 patients with solid malignant tumours attending for radionuclide bone scans....

Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis.

Ralston, S H, Urquhart, G D, Brzeski, M, Sturrock, R D

OBJECTIVE--To determine the prevalence of vertebral compression fractures due to osteoporosis in patients with ankylosing spondylitis. DESIGN--Prospective study of 111 consecutive patients; patients...

Screening for proteinuria in a rheumatology clinic: comparison of dipstick testing, 24 hour urine quantitative protein, and protein/creatinine ratio in random urine samples.

Ralston, S H, Caine, N, Richards, I, O'Reilly, D, Sturrock, R D, Capell, H A

Measurements of protein/creatinine ratio in 'spot' urine samples were compared with measurements of 24 hour quantitative proteinuria and side room 'dipstick' testing in 104 samples from 90 patients...

Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis.

Ralston, S H, Hacking, L, Willocks, L, Bruce, F, Pitkeathly, D A

A placebo controlled, double blind study of aminohydroxypropylidene bisphosphonate (APD), given by monthly intravenous infusion, was conducted in 40 patients with rheumatoid arthritis. Biochemical...

Hypercalcaemia in rheumatoid arthritis revisited.

Ralston, S H, Fraser, W D, Jankowski, J, Richards, I M, Cowan, R A, Capell, H A, ...

The prevalence and mechanisms of hypercalcaemia were studied in a series of patients attending a regional referral centre for rheumatic diseases. In a prospective study one case of hypercalcaemia due...

An unusual case of pustulotic arthro-osteitis affecting the leg, and erosive polyarthritis.

Ralston, S H, Scott, P D, Sturrock, R D

Pustulotic arthro-osteitis is a syndrome, originally described in Japan, in which a sterile inflammatory osteitis of the sternoclavicular region occurs in combination with a non-erosive arthritis,...

Clinical experience with pamidronate in the treatment of Paget's disease of bone.

Gallacher, S J, Boyce, B F, Patel, U, Jenkins, A, Ralston, S H, Boyle, I T

Bisphosphonates have been shown to be effective in treating the increased bone turnover associated with Paget's disease of bone. In this study two groups of patients were treated with pamidronate by...

A new method for the radiological assessment of vertebral squaring in ankylosing spondylitis.

Ralston, S H, Urquhart, G D, Brzeski, M, Sturrock, R D

A method has been developed for the objective assessment of vertebral 'squaring' based on quantitative morphometric analysis of vertebral 'concavity' in lateral radiographs of the lumbar spine. The...

Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study.

MacDonald, A G, Murphy, E A, Capell, H A, Bankowska, U Z, Ralston, S H

AIMS--To study the effects of ovarian hormone replacement therapy (HRT) on bone mineral density and disease activity in postmenopausal women with rheumatoid arthritis (RA). METHOD--A placebo...

Steroid induced osteoporosis: an opportunity for prevention?

Peat, I D, Healy, S, Reid, D M, Ralston, S H

OBJECTIVE--To determine the frequency with which osteoporosis prophylaxis is given to corticosteroid treated hospital inpatients. METHODS--All patients receiving systemic corticosteroids in a large...

Medical management of hypercalcaemia.

Ralston, S H

1. Hypercalcaemia is a common disorder, which frequently requires specific treatment either to control symptoms, or to prevent the development of irreversible organ damage or death. Although the best...

Oat cell carcinoma of bronchus presenting as an acute psychiatric illness in young women

Ralston, S. H., Fogelman, I., Lowe, G. D. O.

Two young women are described who presented with an acute psychiatric illness, due to the metabolic effects of inappropriate anti-diuretic hormone (ADH) secretion. In both patients symptoms were...

'Apathetic' thyrotoxicosis presenting with hypercalcaemia and spurious normalization of serum thyroid hormone levels.

Ralston, S. H., Fraser, W. D., Soukop, M., McKillop, J. H.

A patient with thyrotoxicosis presented with weight loss and hypercalcaemia, leading to an erroneous diagnosis of occult malignant disease. Intercurrent illness and drug treatment of hypercalcaemia...

Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.

Gallacher, S. J., Ralston, S. H., Dryburgh, F. J., Logue, F. C., Allam, B. F., Boyce, B. F., ...

Immobilization-related hypercalcaemia is an uncommon but important condition being associated not infrequently with both urolithiasis and osteoporosis. In this study 5 patients who had been...

Genetic variation in the TNFRSF11A (RANK) gene contributes to the risk to develop sporadic Paget's disease of bone

Chung, P. Y. J., Beyens, G., Riches, P. L., Van Wesenbeeck, L., Jennes, K., Daroszewska, A., ...

[Chung, P. Y. J.; Beyens, G.; Van Wesenbeeck, L.; Jennes, K.; Van Hul, W.] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium. [Chung, P. Y. J.; Beyens, G.; Van Wesenbeeck, L.; Jennes, K.; Van...

Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.

Ralston, S. H., Thiébaud, D., Herrmann, Z., Steinhauer, E. U., Thürlimann, B., Walls, J., ...

Hypercalcaemia is an important cause of morbidity in malignant disease. We studied the efficacy and safety of intravenous ibandronate (a new, potent bisphosphonate) in a multicentre study of 147...